Skip to main content

and
  1. Article

    Open Access

    Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation

    This study aimed to identify the benefits of autologous-stem cell transplantation (auto-SCT) and allogeneic-SCT (allo-SCT) in patients with aggressive T-cell lymphomas to aid in the selection of transplantatio...

    Dong Won Baek, Joon Ho Moon, Jae Hoon Lee, Ka-Won Kang, Ho Sup Lee in Blood Cancer Journal (2023)

  2. No Access

    Article

    Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia

    Secondary-type mutations (STMs), namely SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, and STAG2, are more frequently detected in secondary acute myeloid leukemia (AML) than in de novo AML. Whether de novo AML wi...

    Ga-Young Song, TaeHyung Kim, Seo-Yeon Ahn, Sung-Hoon Jung in Bone Marrow Transplantation (2022)

  3. Article

    Open Access

    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma

    The clinical outcome of advanced-stage Extranodal NK/T cell lymphoma (ENKTL) patients using conventional chemotherapy is extremely poor. The aim of this study was to investigate the outcomes of advanced-stage ...

    Ga-Young Song, Dok Hyun Yoon, Cheolwon Suh, Joon Ho Moon in Bone Marrow Transplantation (2021)

  4. No Access

    Article

    Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment

    Renal insufficiency (RI) is a frequent manifestation of multiple myeloma (MM) at time of diagnosis but there is no reliable prognostic factor for patients with MM presenting with RI. This study investigated th...

    Seo-Yeon Ahn, Hwa Kyung Park, Joon Ho Moon in International Journal of Hematology (2021)

  5. No Access

    Article

    Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

    In patients with acute myeloid leukemia (AML) consolidation treatment options are between allogeneic hematopoietic stem cell transplantation (HCT) and chemotherapy, based on disease risk at the time of initial...

    Jae-Sook Ahn, TaeHyung Kim, Sung-Hoon Jung, Seo-Yeon Ahn in Bone Marrow Transplantation (2021)